TITLE

CLINICAL UTILITY OF DOPAMINE TRANSPORTER SPECT SCANS IN ROUTINE CLINICAL PRACTICE

AUTHOR(S)
Archibald, NK; McKee, PJW
PUB. DATE
March 2008
SOURCE
Journal of Neurology, Neurosurgery & Psychiatry;Mar2008, Vol. 79 Issue 3, p356
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Clinical Utility of Dopamine Transporter Spect Scans in Routine Clinical Practice," by N. K. Archibald and P. J. W. McKee is presented.
ACCESSION #
31313169

 

Related Articles

  • Dopamine hits med/surg. Musselman, Mary; Cerrato, Paul L. // RN;Nov96, Vol. 59 Issue 11, p29 

    Presents a case showing strategies in caring for patients under dopamine treatment. Challenge of dopamine administration on nurses; Accurate monitoring of the patient's response to infusion; Management of extravasation; Clarity in patient instructions; Utilization of clear-cut protocols and...

  • The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats. Spiller, Krista; Xi, Zheng-Xiong; Peng, Xiao-Qing; Newman, Amy; Ashby, Charles; Heidbreder, Christian; Gaál, József; Gardner, Eliot // Psychopharmacology;Mar2008, Vol. 196 Issue 4, p533 

    We have previously reported that selective antagonism of brain D3 receptors by SB-277011A or NGB 2904 significantly attenuates cocaine- or nicotine-enhanced brain stimulation reward (BSR). In the present study, we investigated whether the selective D3 receptor antagonists SB-277011A and NGB 2904...

  • The versatility of dopamine antagonists. Morris, David // GP: General Practitioner;12/2/2002, p48 

    Reports on the use of dopamine antagonists for the treatment of various diseases. List of diseases treated with the drug; Function of the drug; Side-effects associated with the drug; Use of dopamines in the treatment of migraines.

  • The Pleasure Center.  // Scholastic Choices;Oct2002, Vol. 18 Issue 2, HEADS UP REAL NEWS... pIII 

    Provides information on the dopamine in the brain. Effect of the chemical on body; Recognition on the pleasurable experiences; Role of senses on sending signals.

  • Cocaine abuse: hard knocks for the dopamine hypothesis? Caine, S. Barak // Nature Neuroscience;Jun98, Vol. 1 Issue 2, p90 

    The idea that cocaine's reinforcing effects are due to its action at the dopamine transporter is challenged by a new finding that mice lacking this protein self-administer cocaine.

  • Blockade of mesolimbic dopamine transmission dramatically increases sensitivity to the rewarding effects of nicotine in the ventral tegmental area. Laviolette, S R; van der Kooy, D // Molecular Psychiatry;2003, Vol. 8 Issue 1, p50 

    Nicotine produces rewarding and aversive motivational effects in humans and other animal species. Here, we report that the mammalian ventral tegmental area (VTA) represents a critical neural substrate for the mediation of both the rewarding and aversive properties of nicotine. We demonstrate...

  • Cocaine self-administration in dopamine-transporter knockout mice. Rocha, Beatriz; Fumagalli, Fabio; Gainetdinov, Raul; Jones, Sara; Ator, Robert; Giros, Bruno; Miller, Gary; Caron, Marc // Nature Neuroscience;Aug98, Vol. 1 Issue 4, p330 

    Presents a corrected reprint of the article 'Cocaine self-administration in dopamine-transporter knockout mice,' by Beatriz A. Rocha et al, published in the 1998 issue of the periodical 'Nature Neuroscience.'

  • The antipsychotic potential of l-stepholidine—a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Natesan, Sridhar; Reckless, Greg; Barlow, Karen; Odontiadis, John; Nobrega, José; Baker, Glen; George, Susan; Mamo, David; Kapur, Shitij // Psychopharmacology;Aug2008, Vol. 199 Issue 2, p275 

    l-Stepholidine, a dopamine D2 antagonist with D1 agonist activity, should in theory control psychosis and treat cognitive symptoms by enhancing cortical dopamine transmission. Though several articles describe its impact on the dopamine system, it has not been systematically evaluated and...

  • Individual differences in dopamine release but not rotational behavior correlate with extracellular amphetamine levels in caudate putamen in unlesioned rats. Clausing, P.; Bloom, D.; Newport, G. D.; Holson, R. R.; Slikker Jr., W.; Bowyer, J. F. // Psychopharmacology;1996, Vol. 127 Issue 3, p187 

    It has been postulated that differences in pharmacokinetics do not contribute to the well-known individual variability in response to amphetamine (AMPH), but this is yet to be investigated thoroughly. Therefore, rotational behavior of outbred rats (Sprague-Dawley, 4 months old) was recorded...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics